Inventor
GARLICH JOSEPH R
US35 patents
⚠️ This page may combine multiple inventors who share the name “GARLICH JOSEPH R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DOW CHEMICAL CO
22 patentsUS5286479AFeb 15, 1994
Oral compositions for suppressing mouth odors
DOW CHEMICAL CO125 citations97
US5756065AMay 26, 1998
Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
DOW CHEMICAL CO130 citations96
US5750660AMay 12, 1998
Bicyclopolyazamacrocyclophosphonic acid half esters
DOW CHEMICAL CO82 citations96
US5739294AApr 14, 1998
Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents
DOW CHEMICAL CO84 citations96
US5714631AFeb 3, 1998
Conjugates possessing ortho ligating functionality
DOW CHEMICAL CO78 citations96
US5696239ADec 9, 1997
Conjugates possessing ortho ligating functionality and complexes thereof
DOW CHEMICAL CO82 citations96
US5342604AAug 30, 1994
Complexes possessing ortho ligating functionality
DOW CHEMICAL CO97 citations96
US4882142ANov 21, 1989
Bone marrow suppressing agents
DOW CHEMICAL CO58 citations96
US5652361AJul 29, 1997
Macrocyclic ligands and complexes
DOW CHEMICAL CO109 citations95
US5435990AJul 25, 1995
Macrocyclic congugates and their use as diagnostic and therapeutic agents
DOW CHEMICAL CO140 citations95
US5762907AJun 9, 1998
Frozen radiopharmaceutical formulations
DOW CHEMICAL CO25 citations92
US5320829AJun 14, 1994
Oral compositions for inhibiting plaque formation
DOW CHEMICAL CO21 citations92
US5308606AMay 3, 1994
Method of treating and/or diagnosing soft tissue tumors
DOW CHEMICAL CO28 citations92
US5300289AApr 5, 1994
Phytate antimicrobial compositions in oral care products
DOW CHEMICAL CO33 citations92
US5133956AJul 28, 1992
Radiolabeled metal-binding protein for the treatment of arthritis
DOW CHEMICAL CO49 citations92
US5064633ANov 12, 1991
Macrocyclic aminophosphonic acid complexes, their formulations and use
DOW CHEMICAL CO44 citations92
US5059412AOct 22, 1991
Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
DOW CHEMICAL CO52 citations92
US4976950ADec 11, 1990
Bone marrow suppressing agents
DOW CHEMICAL CO43 citations92
US4937333AJun 26, 1990
Method for purifying aminomethylenephosphonic acids for pharmaceutical use
DOW CHEMICAL CO31 citations92
US5300279AApr 5, 1994
Organic amine phosphonic acid complexes for the treatment of calcific tumors
DOW CHEMICAL CO32 citations90
US5342925AAug 30, 1994
Radioactive compositions for soft tissue tumors
DOW CHEMICAL CO2 citations63
US5318772AJun 7, 1994
Oral compositions for inhibiting calculus formation
DOW CHEMICAL CO5 citations63
SIGNALRX PHARMACEUTICALS INC
9 patentsUS10308662B2Jun 4, 2019
Thienopyranones as kinase and epigenetic inhibitors
SIGNALRX PHARMACEUTICALS INC6 citations83
US9505780B2Nov 29, 2016
Thienopyranones as kinase and epigenetic inhibitors
SIGNALRX PHARMACEUTICALS INC9 citations83
US10174032B2Jan 8, 2019
Heterocyclic compound classes for signaling modulation
SIGNALRX PHARMACEUTICALS INC6 citations81
US9981983B2May 29, 2018
Thienopyranones as kinase inhibitors
SIGNALRX PHARMACEUTICALS INC5 citations79
US9550790B2Jan 24, 2017
Thienopyranones as kinase inhibitors
SIGNALRX PHARMACEUTICALS INC8 citations79
US11472814B2Oct 18, 2022
Thienopyranones and furanopyranones as checkpoint inhibitors and modulators of anti-tumor immunity
SIGNALRX PHARMACEUTICALS INC3 citations72
US12577254B2Mar 17, 2026
Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors
SIGNALRX PHARMACEUTICALS INC0 citations61
US11760762B2Sep 19, 2023
Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors
SIGNALRX PHARMACEUTICALS INC0 citations61
US12570668B2Mar 10, 2026
Single molecule compounds providing multi-target inhibition of BTK and other proteins and methods of use thereof
SIGNALRX PHARMACEUTICALS INC0 citations51